1 MARKET INTRODUCTION 1.1 Market Definitions 1.2 Objective of the Study 1.3 Limitation 1.4 Stake Holders 1.5 Currency Used in Report 1.6 Scope of the Global Smart Insulin Pens Market Study 2 RESEARCH METHODOLOGY OR ASSUMPTION 2.1 Research Methodology for the Global Smart Insulin Pens Market 2.1.1 Main Objective of the Global Smart Insulin Pens Market 3 MARKET SYNOPSIS 4 EXECUTIVE SUMMARY 5 TOP START-UPs UNDER SMART INSULIN PENS INDUSTRY 6 COVID-19 IMPACT 7 GLOBAL SMART INSULIN PENS MARKET REVENUE 8 MARKET INSIGHTS BY TYPE 8.1 First Generation 8.2 Second Generation 9 MARKET INSIGHTS BY USABILITY 9.1 Pre-Filled 9.2 Reusable 10 MARKET INSIGHTS BY END-USER 10.1 Hospitals 10.2 Ambulatory Surgery Centers 10.3 Homecare Settings 11 MARKET INSIGHTS BY REGION 11.1 NORTH AMERICA SMART INSULIN PENS MARKET 11.1.1 United States 11.1.2 Canada 11.1.3 Rest of North America 11.2 EUROPE SMART INSULIN PENS MARKET 11.2.1 Germany 11.2.2 France 11.2.3 United Kingdom 11.2.4 Spain 11.2.5 Italy 11.2.6 Rest of Europe 11.3 ASIA PACIFIC SMART INSULIN PENS MARKET 11.3.1 China 11.3.2 Japan 11.3.3 India 11.3.4 Australia 11.3.5 South Korea 11.3.6 Rest of Asia Pacific 11.4 REST OF THE WORLD SMART INSULIN PENS MARKET 12 SMART INSULIN PENS MARKET DYNAMICS 12.1 Market Drivers 12.2 Market Challenges 12.3 Impact Analysis 13 LEGAL & REGULATORY FRAMEWORK 14 DEMAND AND SUPPLY SIDE ANALYSIS 14.1 Demand Side Analysis 14.2 Supply Side Analysis 14.2.1 Top Product Launches 14.2.2 Top Business Partnerships 14.2.3 Top Merger & Acquisitions 15 VALUE CHAIN ANALYSIS 16 SMART INSULIN PENS MARKET OPPORTUNITIES 17 SMART INSULIN PENS MARKET TRENDS & INSIGHTS 18 COMPETITIVE SCENARIO 18.1 Porter’s Five forces analysis 18.1.1 Bargaining power of Supplier 18.1.2 Bargaining power of Buyer 18.1.3 Industry Rivalry 18.1.4 Availability of Substitute 18.1.5 Threat of new Entrants 19 COMPANY PROFILED 19.1 Medtronics 19.1.1 Key Facts 19.1.2 Business Description 19.1.3 Key Product/Services Offerings 19.1.4 Growth Strategy 19.1.5 SWOT Analysis 19.1.6 Key Financials 19.1.6.1 Revenue Split 19.1.6.2 Financial Overview of Medtronics 19.1.7 Recent Developments 19.1.7.1 Product Launch 19.1.7.2 Partnerships 19.1.7.3 Business Expansion and Investments 19.1.7.4 Merger and Acquisition 19.2 Eli Lilly and Company 19.3 Novo Nordisk 19.4 Companion Medical, DIAMESCO 19.5 Emperra GmbH 19.6 Companion Medical 19.7 Ypsomed holding AG 19.8 F. Hoffmann-La Roche AG 19.9 Insulet Corporation 19.10 Snuza International 20 DISCLAIMER

Eli Lilly and Company, Novo Nordisk, DIAMESCO, Emperra GmbH, Ypsomed holding AG, F. Hoffmann-La Roche AG, Insulet Corporation, Jiangsu Delfu medical device Co., and Medtronics